UPDATED Nov. 27, 2012, with comment from Leerink Swann analyst Danielle Antalffy, closing share price.
Cardiovascular Systems (NSDQ:CSII) said it’s enrolled the 443rd and final patient in a clinical trial of its Diamondback 360 atherectomy device for clearing calcium deposits from blood vessels.